- Location
next generation sequencing
"-
Neogen Extends Food Safety Genomic Testing
Jun 21, 2017Neogen has made available next generation sequencing services for the food industry, which will allow food companies to accurately find all bacteria in a sample in a single genomic test. Neogen's new NeoSeek genomic services utilize a ...
-
AMSBIO Has Launched CancerSeq
Feb 27, 2014AMSBIO has launched CancerSeq™ - a new range of genetically characterised FFPE tissue samples. CancerSeq™ samples are prepared from genomic DNA extracted from the FFPE tumour tissues and validated by Next Generation ...
-
Scientists at The University of California,San Diego Have Developed a New Genetic Platform
Jan 22, 2014Scientists at the University of California, San Diego have developed a new genetic platform that allows efficient production of naturally occurring molecules, and have used it to produce a novel antibiotic compound. Their study, published ...
-
Fluxion Biosciences Announced The Release of a New Reagent Kit for The IsoFlux System
Jan 21, 2014Fluxion Biosciences, Inc. announced the release of a new reagent kit for the IsoFlux System designed to provide more options for circulating tumor cell (CTC) and other rare cell capture from biological samples. The IsoFlux Rare Cell ...
-
Sapio Sciences Is Pleased to Announce The Release of Exemplar NGS LIMS
Jan 20, 2014Sapio Sciences is pleased to announce the release of Exemplar NGS LIMS™. Sapio's NGS LIMS system will track multiple next-generation sequencing (NGS) platform workflows from request through processing and analysis. Sapio has gained ...
-
SLAS Has Announced a Partnership with Coastal Genomics to Launch The New Workstation
Jan 20, 2014At the annual Society for Laboratory Automation and Screening (SLAS) meeting Hamilton Robotics has announced a partnership with Coastal Genomics to launch the new Microlab® NIMBUS® Select workstation with Ranger Technology. The new ...
-
NASDAQ:ILMN Entered Into a Multi-Year Licensing Agreement with Quest Diagnostics
Jan 10, 2014Illumina, Inc. (NASDAQ:ILMN) today announced it has entered into a multi-year licensing agreement with Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, related to the use of Illumina's ...
Tags: Illumina, multi-year licensing agreement, Quest Diagnostics
-
Roche and Kapa Announced a Partnership to Provide NGS Target Enrichment Workflow Solution
Dec 23, 2013Roche NimbleGen and Kapa Biosystems have announced a partnership to provide an optimized next-generation sequencing (NGS) target enrichment workflow solution. Kapa Biosystems will custom manufacture NGS library preparation products for ...
Tags: Roche, Kapa Biosystems
-
Foundationone Heme Has Been Launched by Foundation Medicine
Dec 11, 2013Foundation Medicine, a molecular information company, has announced the launch of its second clinical product, FoundationOne Heme, a fully informative genomic profile for hematologic cancers (leukemia, lymphoma and myeloma), as well as many ...
-
Availability of Alpha-1 Diagnosing Kit Has Been Announced by CSL Behring
Nov 27, 2013US-based CSL Behring has announced the availability of DNA1 Advanced Alpha-1 Screening (DNA1), a new test kit designed to improve diagnosis of Alpha-1 antitrypsin deficiency (Alpha-1). Alpha-1 is a serious hereditary condition that is ...
Tags: Diagnosing Kit, CSL Behring
-
SCT and ABB Have Entered Into a Collaboration to Identify New Therapeutic Antibodies
Nov 22, 2013Single Cell Technology (SCT) and AB Biosciences (ABB) have entered into a collaboration to identify new therapeutic antibodies. Under the deal, SCT will use its patented platform to screen plasma cells, measure the kinetics of secreted ...
-
Illumina Has Obtained Premarket Clearance From FDA for The Miseqdx System
Nov 22, 2013US-based Illumina has obtained premarket clearance from the US Food and Drug Administration (FDA) for the MiSeqDx system, a high-throughput DNA sequencing analyzer. The company has also obtained premarket clearance from the FDA for the ...
Tags: Illumina, MiSeqDx System
-
Cancerplex for Genomic Testing of Cancer Was Launched by KEW
Oct 29, 2013KEW Group, the oncology personalized medicine management and analytics company, has launched CancerPlex assay, a comprehensive gene testing panel that can be used to examine the genetic profile of many common cancers. Developed and ...
Tags: Genomic Testing, Medicine
-
Illumina Has Announced The Introduction of Its TruGenome Undiagnosed Disease Test
Oct 24, 2013US-based Illumina has announced the introduction of its TruGenome undiagnosed disease test provided by Illumina Clinical Services Laboratory (ICSL). Using whole human genome sequencing, the TruGenome test helps clinicians in identifying ...
Tags: Illumina, Undiagnosed Disease Test
-
Analytic Validation Study'Publication of Foundationone Is Reported by Foundation Medicine
Oct 22, 2013Foundation Medicine, molecular information company, has announced that results from a 24-month, multi-institution collaboration demonstrating the analytic validation of its cancer genomic profiling assay, FoundationOne, were published in ...
Tags: Foundation Medicine
